CINF vs IBRX · P/E 16, rev $7.14B vs rev $51.2M
Cincinnati Financial Corporation (CINF) versus Immunitybio Inc (IBRX) — a side-by-side from cached financials, not a winner call.
Cincinnati Financial Corporation (CINF) is a insurance - property & casualty company listed on US.
Immunitybio Inc (IBRX) is a biotechnology company listed on US.
Latest reported CINF revenue for 2026-06-30 was $7.14B. Net income was $1.53B. CINF currently screens at market cap $22.83B and trailing P/E 15.9.
Latest reported IBRX revenue for 2026-06-30 was $51.2M. Net income was -$230.4M. Revenue was up 15.9% from 2026-03-31 to 2026-06-30. IBRX currently screens at market cap $7.88B.
CINF currently screens at market cap $22.83B and trailing P/E 15.9. IBRX currently screens at market cap $7.88B.
Not investment advice. Open the CINF and IBRX stock pages for the full models.
Not investment advice.